Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Number of holders
-
359
-
Total 13F shares, excl. options
-
88,883,200
-
Shares change
-
+2,145,462
-
Total reported value, excl. options
-
$6,839,668,471
-
Value change
-
+$166,333,622
-
Put/Call ratio
-
22.36%
-
Number of buys
-
190
-
Number of sells
-
-153
-
Price
-
$76.96
Significant Holders of RESMED INC - Common Stock (RMD) as of Q3 2017
410 filings reported holding RMD - RESMED INC - Common Stock as of Q3 2017.
RESMED INC - Common Stock (RMD) has 359 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 88,883,200 shares
of 146,467,184 outstanding shares and own 60.68% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (14,140,176 shares), BlackRock Inc. (11,121,045 shares), Capital World Investors (10,616,700 shares), FMR LLC (7,230,648 shares), STATE STREET CORP (5,817,283 shares), BAILLIE GIFFORD & CO (4,913,626 shares), Commonwealth Bank of Australia (1,977,179 shares), Bank of New York Mellon Corp (1,751,561 shares), NORTHERN TRUST CORP (1,673,822 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,655,297 shares).
This table shows the top 359 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.